fats and fatty acids Flashcards

1
Q

LIPIDS: CLASSIFICATION

what are htey made of

A
composed of C, H and O
• ratio of O to C's and H's lower than
with CHO
• relatively insoluble in H2O
• soluble in nonpolar solvents
– e.g., ether, chloroform, benzene
• energy releasing nutrient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

A. Simple Lipids

A
  1. Fatty acids (FAs)
  2. Neutral fats - monoglycerides (MG)
    - diglycerides (DG)
    - triglycerides (TG)
    [triacylglycerols]
  3. Waxes - esters of FAs with ↑ alcohols
    a. Sterol esters: e.g,, cholesterol esters
    b. Non-sterol esters: e.g., Vit A esters, etc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

B. Compound Lipids

A
  1. Phospholipids
    a. Phosphatidic acids
    e. g., lecithin, cephalins
    b. Plasmalogens
    c. Sphingomyelins
  2. Glycolipids - carbohydrate containing
  3. Lipoproteins - lipids associated with ptn
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

C. Derived Lipids

A
derivatives formed from A and B
• possess general properties of lipids
• soluble in organic solvents
– e.g., ether, chloroform, acetone
• fat-soluble vitamins
• corticosteroid hormones
• coenzyme Q (electron transport)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

STRUCTURE AND FUNCTION

A

FATTY ACIDS (FAs)
Basic unit of lipids is FA
- building block of other lipids
defined by # of Cs and presence of double bonds
H3C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C=O
|
OH
nonpolar(omega end), hydrophobic polar, hydrophillic
(lengthening end)
No double bonds (DB): Saturated
With double bonds (DB): Unsaturated - 1, 2, 3 or 4 DBs
- cis or trans (cis common)
even # Cs in FA: naturally occurring (plants/animals)
odd # Cs in FA: occur is small amts in food

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Physical Properties:

A

Melting point of a FA (and TG containing it) will ↓ with:
1. the shorter the chain
2. the higher the degree of unsaturation i.e., # of DBs
Hydrogenation:
- UFA → SFA ( liquid → solid )
- adding H+ to DBs (less rancid, ↓ [O])
- cis UFA → SFA → cis UFA or trans UFA
- used for “margarine” production
- trans FAs are UFAs but act like SFA
i.e., solid, no EFA properties, ↑ blood cholesterol
- consumer beware (food labels)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Fatty Acids: Names & Sources

A

If chain is short: Short Chain (Volatile) FA
2:0 = acetic (GI fermentation)
3:0 = propionic (GI fermentation)
4:0 = butyric (butter, GI)
If chain is medium length (6-14C): Medium Chain FA
12:0 = lauric
14:0 = myristic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Fatty Acids: Names & Sources

A
If chain is long (16-20C): Long Chain FA
16:0 = palmitic (common)
18:0 = stearic (common)
20:0 = arachidic
There are fatty acids with C>20
Very Long Chain FAs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

One double bond = monounsaturated (MUFA)

A
H3C-C-C-C-C-C-C-C-C=C-C-C-C-C-C-C-C-C=O
 |
 OH
16:1 = palmitoleic
18:1 = oleic (olive) [common]
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

2 or more double bonds = polyunsaturated (PUFA)

A
H3C-C-C-C-C-C=C-C-C=C-C-C-C-C-C-C-C-C=O
 |
 OH
"ω" or "n" delta (Δ)
18:2(9,12) 18:2Δ9,12 18:2ω6 18:2n6 = linoleic
18:3(9,12,15) 18:3Δ9,12,15 18:3ω3 18:3n3 = α-linolenic
20:4n6 = arachidonic
20:5n3 = eicosapentaenoic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

3 families of unsaturated FAs:

A
  1. n-3 = ω3 = delta 9,12,15
    18: 3n3 → 20:5n3 (eicosapentaenoic [EPA] fish)
    - classified as “essential” (α-linolenic)
    - 20:5n3 precursor to “eicosanoids” (PG3)
    - hypolipidemic, antithrombotic effects
    - 22:6n3 (docosahexenoic acid - fish)
    - membrane phospholipid, cerebrum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

3 families of unsaturated FAs:

A
  1. n-6 = T6 = delta 9,12
    18:2n6 → γ-linolenic (18:3n6)→ 20:3n6 → 20:4n6
    seeds (18:2n6 linoleic ) → 20:3n6 → 20:4n6 → PG2
    └→ PG1
    animals (20:4n6 arach) → PG2
    - classified as “essential” (linoleic)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

3 families of unsaturated FAs:

A
  1. n-9 = delta 9
    16:0 → 18:0 → 18:1 (oleic) → ≠ 18:2n6
    → ≠ 18:3n3
    - animals can convert (18:0 → 18:1→ 20:3)
    - no known function of 20:3
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Eicosanoids:

A
arachidonic acid (20:4n6)*
eicosatrienoic acid (20:3n6)
eicosapentaenoic acid (20:5n3)*
↓ [Ox]
prostaglandins (P)
thromboxanes (T)
leukotrienes (L)
* more common in food
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Prostaglandins

A

18:2n6 → PG1 & PG2 20:4n6 → PG2 18:3n3 → PG3
- 20 Cs, 5 C ring, # DBs, small structural difference
e.g., PGD, PGE, PGF, PGI, PGG, PGH
Eicosanoid Function:
- immune fn effects
- gastric secretions
- vasodilators (↓ BP) or vasoconstrictors,
- ↑ smooth muscle contraction
- ↓ or ↑ platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NEUTRAL FATS

A

Triglycerides (TG) = Triacylglycerols
TG = glycerol + 3 FAs (ester bonds)
- simple TG = same FAs / mixed TG = different FAs
- “high energy” storage form of body fat
- adipose TG → free FA → body tissue → OX
- 95% of dietary fat as TGs
- TG exist as fats (solids) or oils at room temp
- depends on FA composition (oil = SCFAs and ↑ DBs)
Diglycerides (DG) = glycerol + 2 FAs
Monoglycerides (MG) = glycerol + 1 FA
- negligible in tissues
- intermediate in some metabolic reactions
e.g., lipases - digestion, hydrolyse TG
- component of other lipids
- in food, emulsifying agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

STEROLS AND STEROIDS

A
steroid = 4-ring hydrocarbon structure
sterol = monohydroxy alcohol of steroid
e.g., - cholesterol synthesized in animals
- other sterols found in plants
 e.g., ergosterol)
Cholesterol - NB component of cell membrane
- precursor for other steroids
 cholesterol + FA = cholesterol ester
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

PHOSPHOLIPIDS

A

5% of fat intake
– food emulsifiers, plants & animals
1. glycerol + 2 FAs [1,2 Cs] + (Pi + base [3 C])
base = choline (lecithin), inositol etc
2. sphingomyelins (FA + Pi + sphingosine)
- myelin sheath of nerve tissue
- polar structures (hydrophillic properties)
- chylomicrons
- cell and organelle membranes (regulator of passage)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

GLYCOLIPIDS (GL)

A

backbone of GL (Ceramide = FA + sphingosine)
- GL contains no Pi
Cerebrosides - ceramide + monosaccharide (MS)
(GLU,GAL)
Gangliosides - ceramide + oligosaccharide
(MS derivative)
- structure of cell membranes
- “recognition markers” on exterior of membrane
- cell identity (NB for immune system)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

LIPOPROTEINS (LP)

A
transport form of lipids in blood
- 5 main classes: chylomicrons
very low density lipoptn (VLDL)
intermediate density lipoptn (IDL)
low density lipoptn (LDL)
high density lipoptn (HDL)
Plus: FFA bound to albumin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

omega-3 vs omega 6

A

3 makes the 3

6 makes the 1 and 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

giglycerides

A

glycerol + 2 FAs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Monoglycerides (MG)

A

glycerol + 1 FA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

NEUTRAL FATS

A
Diglycerides (DG) = glycerol + 2 FAs
Monoglycerides (MG) = glycerol + 1 FA
- negligible in tissues
- intermediate in some metabolic reactions
e.g., lipases - digestion, hydrolyse TG
- component of other lipids
- in food, emulsifying agents-
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

STEROLS AND STEROIDS

A
steroid = 4-ring hydrocarbon structure
sterol = monohydroxy alcohol of steroid
e.g., - cholesterol synthesized in animals
- other sterols found in plants
 e.g., ergosterol)
Cholesterol - NB component of cell membrane
- precursor for other steroids
 cholesterol + FA = cholesterol ester
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

steroid

A

steroid = 4-ring hydrocarbon structure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

sterol =

A

monohydroxy alcohol of steroid (added OH on the molecules)

e. g., - cholesterol synthesized in animals
- other sterols found in plants
e. g., ergosterol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

cholesterol ester

A

cholesterol + FA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

PHOSPHOLIPIDS

A

(95% as triglycerides) 5% of fat intake (from cell membranes)
– food emulsifiers, plants & animals
1. glycerol + 2 FAs [1,2 Cs] + (Pi + base [3 C])
base = choline (lecithin(eggs)), inositol etc
2. sphingomyelins (FA + Pi + sphingosine)
- myelin sheath of nerve tissue
- polar structures (hydrophillic properties)
- chylomicrons
- cell and organelle membranes (regulator of passage)

the phosphate group is the hydrophylic part, (2 fa and a phosphate group and a pase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

sphingomyelin

A

ceramide with a choline(base) with a phosphate group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

GLYCOLIPIDS (GL)

A
  • backbone of GL (Ceramide = FA + sphingosine)
  • GL contains no Pi
    Cerebrosides - ceramide + monosaccharide (MS)
    (GLU,GAL)
    Gangliosides - ceramide + oligosaccharide
    (MS derivative)
  • structure of cell membranes
  • “recognition markers” on exterior of membrane
  • cell identity (important for immune system)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

ceramide

A

sphingogosine with faty acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Cerebrosides

A
  • ceramide + monosaccharide (MS)

GLU,GAL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Gangliosides

A
  • ceramide + oligosaccharide

MS derivative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

LIPOPROTEINS (LP)
5 main kinds

wont ever ask us to draw but know what theyre made up of,

A
  • transport form of lipids in blood
  • 5 main classes: chylomicrons (82% triglyceride, 7% phospholipids, 2% cholesterol9% protein)

very low density lipoptn (VLDL) (54% tryglyceride, 18%phospholipds, 22% cholesterol, 7% protein- made in the liver to transport extra fats from liver from diet to tissue, high in phospholipids because made in liver tot ransport to other tissues to rejevenate cell membranes, high in cholesterol from liver (made there)liver making fats to destribute to rest of body)

intermediate density lipoptn (IDL)( 31% triacylglyceride, 22%…)
low density lipoptn (LDL) (9% triacylglecerides, 23% phospholipid, 47% cholesterol, droped off tri to the adipose tissue - the “bad” cholesterol, 21% protein )
high density lipoptn (HDL)( 3% tri, 28% phospholipids, 19% cholesterol, 50% protein - rejevinate cell membrane and pick up LDL cholesterol
Plus: FFA bound to albumin (very dense lipoprotein, no apoprotein coding)

outer layer of protein,

improve HDL by physical activity, MUFAS,
chylomicron half life is really short just from intestine to the liver- about 1 hour, LDL stick around

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

MAJOR FUNCTIONS OF LIPIDS

IN THE BODY:

A
  1. As a compact storage of NRG (TG)
  2. As thermal insulator (TG in adipose tissue)
  3. As a “cushion” to support internal organs
    • e.g., kidneys (TG in adipose)
  4. As a constituent of membranes of all cells and cell organelles
    • PL, GL, sterols
  5. As a constituent of myelin sheath
    • complex/derived fats, e.g., cerebrosides
  6. Precursors to essential compounds (FAs)
    e.g., eicosanoids: PG, thromboxane, leucotriene
    18:2n6→→→18:3n6 → 20:3n6 (→PG1) → 20:4n6 → PG2
    18:3n3 → 20:4n3 → 20:5n3 →PG3
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

MAJOR FUNCTIONS OF LIPIDS

B. AS A FOOD COMPONENT:

A
  1. High energy value (9 kcal or 38 kJ per gram)
  2. As a source of essential fatty acids (EFAs)
  3. As a medium for fat-soluble vitamins and a
    requisite for their digestion and transport in the
    blood from absorption
  4. Provide flavour and aroma to food
  5. High satiety value (delay gastric emptying)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Dietary Sources & Health Implications

• Foods containing MCFAs (10-14 Cs):

A

coconut, palm kernel (“tropical oils”), MCT oil
- liquid at room temperature
- SFA but not long chain
- ↓ intake since these ↑ serum cholesterol,
especially LDL

NOT PART OF MICELLE- WHICH GOES TO CHYLOMICRON TO THE LYMPHATIC SYSTEM- PPL WITH BAD LYMPH SYSTEM TAKE THESE FATS FOR ENERGY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Dietary Sources & Health Implications

• Foods containing long chain (LC) SFA:

A

dairy, lard, tallow (“animal”), cocoa
SFA: suggest ↓ to <10% energy
- solid at room temp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Dietary Sources & Health Implications

• Foods containing MUFA:

A

olive, canola, peanut
MUFA do not raise serum cholesterol
- use to replace SFA
- extra fat as MUFAs (Mediterranean Diet)

good SUBSTITUTE FOR SATURATES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Dietary Sources & Health Implications

• Foods containing PUFA as n-6:

A

seed oils: corn, soy, safflower (linoleic 18:2n6,9)
18:2n6,9 → (desaturation) → 18:3n6,9,12 (GLA)
- primrose, borage (supplement)
• Foods containing PUFA as n-3:
18:3n3,6,9 = α-linolenic
canola 10%, linseed, soy 7% (vegetables n-3)
20:5n3 = eicosapentaenoic (EPA)
fish: fatty fish or fish liver oils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

PUFAs and MUFAs

A
Want M&amp;P/S ratio > 1
- so can ↓ S and ↑ M&amp;P without ↑
total fat
- too much P not good →
eicosanoids problems

more monos and pufas than saturated

prostaglandins- heart health, can be vasoconstrictor if too much because participate in platelets- dont go crazy on the 6s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

DIGESTION AND ABSORPTION

A

pancreatic lipase breaks them down
4 interacting factors are essential for normal fn of the
intestines in fat absorption:
1. secretion of hydrolytic enzymes from pancreas to break
ester linkages of TG
2. release of detergents (bile salts) in the bile to emulsify
fats and breakdown products
3. uptake of digestion products into mucosal cells (villi) of SI
4. conversion of digestion products into particles for
transport from MCs to lymph system & blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

DIGESTION AND ABSORPTION

Failure:

A

fat in the faeces (i.e., steatorrhoea)

  • diarrhoea
  • H2O & electrolyte loss
  • ↓ absorption of nutrients
  • fat soluble vitamins
  • starvation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

DIGESTION

LIPOLYSIS:

A

hydrolysis by pancreatic enzymes called lipases
- in duodenum, - lipids mix with secretions
- emulsions form
- lipases act
TG → 2-MG + 2FAs → Na salts (TG/DG ≠ absorbed)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

DIGESTION

BILE SALTS AND MICELLES:

A
bile salts: - detergents (hydrophilic &amp; hydrophobic)
- formed by [O] of cholesterol in liver
- "mixes" with lipids (↑ surface area)
- form emulsions → lipase attack
- part of micelles → absorption
(enterohepatic circulation)

micelles: - bulky hydrophilic ends outside (aqueous)
- narrow hydrophobic ends inside
- smaller than emulsions
- absorbed by mucosal cell of SI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

ABSORPTION

of bile salts

A
  1. Micelles (MG and FFAs) absorbed into MC
    - glycerol, SCFAs, MCFAs absorbed directly
    - do not require to be part of micelle
    - absorbed into MC → blood
  2. MG and FFAs reesterified → TG
    - requires nrg (FA activated to acyl-CoA deriv)
  3. TG, cholesterol, chol esters, PLs, fat sol Vits
    → stabilized by surface layer of ptn and PLs
    - lipid droplet discharged from MC
    - chylomicron (CM)
  4. CM enter lymphatics → blood (thoracic duct)
  5. Circulating CM → lipoptn lipase → FAs
    + glycerol
    - after meal, ↑ FA → adipose (↑ insulin)
    - also FAs → ↑ other body tissues
    - glycerol / CM remnants taken up by liver
    - “clearance” of CM = ½ time < 1 h in humans
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

chylomicron is composed of

A

phospholipids, cholesterol, protein, triacylglyceride (made from fatty acids, monoacylglycerol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

albumin

A

direct absorption of short chian free fatty acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

METABOLISM

IN LIVER

A

IN LIVER
1. SCFAs → portal circulation (via plasma albumin) → liver → FA [O]
2. bile salt (BS)
portal circulatn → liver → BS pool → bile duct → SI →
recycling: enterohepatic circulation
3. other lipids enter liver via the hepatic artery
1. CMR (eg, sterols) → blood → membrane receptors
2. Adipose → FFAs → blood (via albumin) → FA [O]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

where do bile salts go

A

not part of chylomicron- goes to lipid from portal vein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

LIPID METABOLISM: LIVER

A
  • hepatic cells play central role in lipid metabolism:
    1. FA [O] (exogenous lipids)
    2. FA synthesis (endogenous lipids from glu)
    3. biosynthesis of cholesterol (and bile salts)
    4. formation of phospholipids (of blood plasma)
    5. formation of lipoproteins
    6. regulatory role in storage of fats in tissues
    (fat storage in liver is small < 1% of mass)
  • regulatory role of liver fails: fatty liver
    e.g., toxicity (ie, EOH)
    7. production of ketone bodies (alternative nrg)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

2 types of fatty liver disease

A

non-alcoholic liver disease,

cirhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q
  1. FATTY ACID OXIDATION
A

• in “fasted state”, FAs important nrg source
– liver priority: glycogen → glu → oblig glu users
• compact fuel (> nrg produced)
• lipids consist mainly of C & H:
– [O] involves consumption of&raquo_space; O2
– Thus, > ATP production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

[O] PATHWAY

A
  • mitochondria (linked to TCA cycle and e- TC)
    1. activation of FAs to acyl-CoA thio esters
    • requires nrg [also step in making fats / PLs]
    2. mitochondria entry of FA-CoA requires carnitine
    (carrier molecule)
    3. β oxidation
    • cyclic series of rxns where Hs removed and 2C units split off as
    acetyl-CoA (come off in twos- 18c= 8 cycles, 16c=7cycles)
    4. TCA [O] of acetyl CoA to yield H and CO2
    • nrg yield from complete [O] is great:
    • β oxidation alone is 1/3 that of TCA [O]
56
Q

OXIDATION OF PALMITATE

A

RECALL: [O] of Reducing Equivalents through eTC
1 mol NADH + H+ → 3 ATP (protons & e- → FMN)
1 mol FADH2 → 2 ATP (protons & e- → QH)
Thus, calculate efficiency of nrg capture in ATP from [O] of 1 mol of palmitate
(16:0) [256g]
1. Physiological fuel value of 256 g 16:0 = 256 x 38 KJ = 9728 KJ
2. Free nrg of hydrolysis of 1 mol ATP → ADP + Pi = 31.0 KJ
Therefore, [O] of 1 mol palmitate:
Activation - 2 ATP equivalents
7 “passes” thru β [O] [(7 x 2) + (7 x 3)] + 35 ATP equivalents
8 mols acetyl-CoA thru TCA (8 x 12) + 96 ATP equivalents
NET: 129 ATP equivalents
3. 3 times > [O] of 1 mol of glu (38 ATP)
4. Efficiency of nrg capture from 16:0 in ATP = 129 x 31.0 / 9728 x 100% = 40%

57
Q
  1. FATTY ACID SYNTHESIS (LIPOGENESIS)
A

-endogenous synthesis (during “fed” state)
-main precursor for FAs syn is glu (CHO)
- also, excess nrg [CHO,AAs] → TG
FED: glu (1st glycogen) → acetyl-CoA + CO2 → FAs
SYNTHETIC PATHWAY
- cytosol (extramitochondrial)
1. starting material (acetyl-CoA) available
2. transport of acetyl-CoA from mitochondria to cytosol
oxaloacetate + acetyl-CoA → Citrate + CoASH
in cytosol: reconverted (citrate-cleavage enzyme)
3. carboxylation of acetyl-CoA →malonyl CoA
enzyme acetyl-CoA carboxylase - req biotin, ATP
- stimulated by ↑ insulin : glucagon
4. a. condensation of 2 C units (acetyl-CoA + malonyl CoA)
b. reduction to LC-SFAs (palmitate 16:0)
- multienzyme complex: FA synthetase
- Acyl Carrier Protein (ACP)
- source of reducing equivalents (NAPH + H+)
- from PPP in CHO metabolism
5. metabolic fate of palmityl CoA
- elongated (18:0), desaturated (18:1)
- form phosphatidic acid (NB in PL syn)
- used as nrg for liver (β [O] in mitochondria)
- esterified to form TG
e.g., in liver: glycerol 3-P [3-C backbone]
- TG exported on VLDL → tissues
- especially adipose

58
Q

when is biotin used

A

acetyl caa-> malonyl coa (enzyme; acetyl coa carboxylase)

59
Q

18:1

A

omega 9- olive oil

60
Q
  1. BIOSYNTHESIS OF CHOLESTEROL
A
  • endogenous synthesis (liver / intestinal mucosa)
  • in cytosol of cell
    SYNTHETIC PATHWAY (for more see text)
    1. acetyl-CoA → acetoacetyl-CoA (thiolase) → 6C
    β-OH-β-methylglutaryl CoA (HMG-CoA)
    2. HMG-CoA → mevalonate → isoprene (5C) → squalene (30C)

    HMG-CoA reductase (NB “control” enzyme)
    3. → cholesterol → bile acid (salts)
61
Q

what is allosterically inhibited when cholesterol is high

A

HMG CoA reductase

some ppl dont have this

62
Q
  1. FORMATION OF PHOSPHOLIPIDS
A
  • endogenous synthesis (liver)
    WHY?
    1. provide for renewal/adjustment of the structural PLs in
    its own membrane
    2. to release PLs to other tissues via plasma LPs
    3. to provide DG for syn of fats within liver
    SYNTHETIC PATHWAY (for more see text)
    1. glycerol or glycolysis (glu) → α-glycero-P (glycerol 3-P)
    2. αGP + 2FA → phosphatidic acid → PLs & TGs
63
Q
  1. FORMATION OF LIPOPROTEINS
A

for more see text
- LP formation major synthetic fn of liver
- LPs are PL-carrier ptn complexes:
- transport PLs to cell membranes (+ membranes within cell)
- LPs carriers of TG in blood
e.g., Liver Synthesis of Albumin
(albumin + lipid → blood transport → tissues)

64
Q

what does albumion do

A

transports fat in the blood

65
Q

LIPID METABOLISM: ADIPOSE

A
  • adipose tissue can utilize circulating FAs
  • cells have lipoptn lipase → free FAs from LPs
    etc
  • FAs activated to CoA form & reesterified → TG
    (3C backbone from glucose/glycogen)

adipocytes: - specialized cells for fat retention
- active cells:
1. FA synthesis
2. catabolic systems to release FAs
- hormone-sensitive lipase (HSL)
- lipolysis stimulated by ↓ insulin:glucagon
- FFAs (albumin) → tissue / organ
FAs found in adipose:
1. exogenous (of dietary origin)
- reflect FA composition of diet
2. endogenous (from syn from glu in liver, adipose)
- mainly palmitic acid

66
Q

LIPID METABOLISM: MUSCLES

A
  1. capable of β-oxidation
  2. capable of ketone body oxidation
    - β-OH-butyrate and acetoacetate
  3. no capacity for FA or TG synthesis
    “Role of Carnitine”:
    - greater dependence on carnitine in
    muscle for β-oxidation
67
Q

LIPID METABOLISM: BRAIN

A
  • neural tissue is rich in lipid (½ total mass)
  • little TG
  • most complex lipids: PLs, cholesterol, sphingolipids
    1. FA and lipid synthesis from glu (or KBs)
  • FAs → complex lipids
  • FAs do not → TG (storage fat)!!
    2. cholesterol synthesis from acetyl CoA
    3. no β-oxidation (nrg from glu)
    glu → acetyl-CoA → TCA, sterol syn
    4. neurotransmitter synthesis
    glu → acetyl-CoA → acetylcholine
    Genetic Diseases (Lipidoses): ↑ fat in nervous system
    e.g., Tay-Sachs, Niemann-Pick disease, Gaucher’s disease
68
Q

LIPID METABOLISM

OXIDATION

A

Many tissues (except obligate glucose users) can use
FFAs as a source of energy (through β-[O])
e.g., liver, heart (also [O] of KBs), skeletal muscle (also [O] of KBs)

69
Q

LIPOGENESIS

A

Many tissues are capable of FA (TG) synthesis:

e.g., liver, adipose, lactating mammary gland, kidney, brain, lung

70
Q

LIPID METABOLISM: PROLONGED FASTING

i.e.,3 days and onward

A
  1. liver glycogen stores depleted
  2. gluconeogenesis in liver (kidney?) sustains bld glu
  3. mobilization of adipose TG continues same as in
    postabsorptive state (short fast)
  4. liver begins to produce ketone bodies (KBs) as an
    alternate fuel for brain, kidneys, heart / skeletal muscle
    (replaces some glu used by brain / nerves)
71
Q

KETOGENESIS (KB production):

A

production of β-OH-butyrate, acetoacetate, acetone
(true K) by liver from acetyl-CoA from FA [O]
1. depletion of malate (TCA) to support gluconeogenesis
→ ↓ oxaloacetate to support TCA [O]
2. rate of “delivery” of FFAs to liver remains high
- excess liver nrg (ATP) if FAs completely [O] (β and
TCA [O])
3. FAs → acetyl CoA → KB (liver) → blood → body
tissue
- production of an alternate nrg source
- brain + nervous tissue → spares glu
- muscle ptn → spares AAs (↓ proteolysis)
4. utilization of KBs by extrahepatic tissues
e.g., brain, nervous tis, kidneys, skeletal/heart muscle
- acetone expired in lungs (“acid” breath)
- all mitochondrial
β-OH butyrate → acetoacetate → 2 acetyl-CoA (thru TCAcycle)
→ CO2 + H2O + ATP + etc

72
Q

malate maintains

A

blood glucose levels

73
Q

LIPID METABOLISM: PROLONGED FASTING

KETOSIS:

A
  • KB in blood (ketonemia) and urine (ketonuria) > normal
  • β-OH-butyrate and acetoacetate are acids → ↓ bld pH
  • normally not a problem
    e. g., mild starvation, low CHO diets
  • can be problem in uncontrolled diabetes
  • excess KB excretion in urine depletes alkali reserve
    e. g., bicarbonate, potassium, ammonium ions
74
Q

BLOOD LIPIDS

LP classes and composition (1-5 are globulins)

A
  1. chylomicra - ↑↑ fat ↓ increasing densities
  2. VLDL - ↑ fat (TG)
  3. IDL – short lived
  4. LDL - ↑ chol
  5. HDL - ↑ PLs
  6. VHDL - albumin, ↓ fat, some FAs
75
Q

LIPID METABOLISM

OXIDATION

A

Many tissues (except obligate glucose users) can use
FFAs as a source of energy (through β-[O])
e.g., liver, heart (also [O] of KBs), skeletal muscle (also [O] of KBs)

76
Q

LIPOGENESIS

A

Many tissues are capable of FA (TG) synthesis:

e.g., liver, adipose, lactating mammary gland, kidney, brain, lung

77
Q

LIPID METABOLISM: PROLONGED FASTING

i.e.,3 days and onward

A
  1. liver glycogen stores depleted
  2. gluconeogenesis in liver (kidney?) sustains bld glu
  3. mobilization of adipose TG continues same as in
    postabsorptive state (short fast)
  4. liver begins to produce ketone bodies (KBs) as an
    alternate fuel for brain, kidneys, heart / skeletal muscle
    (replaces some glu used by brain / nerves)
78
Q

KETOGENESIS (KB production):

A

production of β-OH-butyrate, acetoacetate, acetone
(true K) by liver from acetyl-CoA from FA [O]
1. depletion of malate (TCA) to support gluconeogenesis
→ ↓ oxaloacetate to support TCA [O]
2. rate of “delivery” of FFAs to liver remains high
- excess liver nrg (ATP) if FAs completely [O] (β and
TCA [O])
3. FAs → acetyl CoA → KB (liver) → blood → body
tissue
- production of an alternate nrg source
- brain + nervous tissue → spares glu
- muscle ptn → spares AAs (↓ proteolysis)
4. utilization of KBs by extrahepatic tissues
e.g., brain, nervous tis, kidneys, skeletal/heart muscle
- acetone expired in lungs (“acid” breath)
- all mitochondrial
β-OH butyrate → acetoacetate → 2 acetyl-CoA (thru TCAcycle)
→ CO2 + H2O + ATP + etc

79
Q

malate maintains

A

blood glucose levels

80
Q

LIPID METABOLISM: PROLONGED FASTING

KETOSIS:

A
  • KB in blood (ketonemia) and urine (ketonuria) > normal
  • β-OH-butyrate and acetoacetate are acids → ↓ bld pH
  • normally not a problem
    e. g., mild starvation, low CHO diets
  • can be problem in uncontrolled diabetes
  • excess KB excretion in urine depletes alkali reserve
    e. g., bicarbonate, potassium, ammonium ions
81
Q

BLOOD LIPIDS

LP classes and composition (1-5 are globulins)

A
  1. chylomicra - ↑↑ fat ↓ increasing densities
  2. VLDL - ↑ fat (TG)
  3. IDL – short lived
  4. LDL - ↑ chol
  5. HDL - ↑ PLs
  6. VHDL - albumin, ↓ fat, some FAs
82
Q

BLOOD LIPIDS

Transport Mechanisms:

A
  1. Chylomicra : carry diet fats (TG) absorbed from gut → adipose
    (+ tissues with lipoptn lipase)
  2. VLDL: carry endogenous TGs (ie, liver) → adipose (+ other tissues)
  3. LDL: cholesterol → peripheral tissue
  4. HDL: - aids (as UFA donor) in conversion of
    chol → chol ester
    - tissue chol → liver → bile excretion
  5. VHDL: - LPs after lipids removed → liver (reutilized)
    - FAs from adipose → albumin bound, FAs → tissue
83
Q

CONCERNS ABOUT LIPIDS

A
  1. Lipid deposition in atherosclerosis (CHD)
    - multi-factor disease
    - risks: genetic
    environmental – smoking
    - diabetes
    - hypertension
    - lack of exercise
    - gross obesity
    - ↑ blood cholesterol
84
Q
  1. The hyperlipidemias (hyperlipoproteinemia)
A

Inherited (inborn errors of metabolism)
a. Type I: absence of lipoptn lipase (breaks tg bonds so that they can be delivered to various tissues- without enzyme would perscribe diet iwht medium and short chain fatty acids so that they dont have to go in a chylomicron)
b. Type II: ↑↑↑ LDL (cholesterol)
c. Type III: ↑ cholesterol & ↑ TG
d. Type IV: ↑ VLDL (TG)
Secondary hyperlipidemias
Environmental Factors: e.g., ↑ calories, ↑ EOH

85
Q

LIPID METABOLISM

OXIDATION

A

Many tissues (except obligate glucose users) can use
FFAs as a source of energy (through β-[O])
e.g., liver, heart (also [O] of KBs), skeletal muscle (also [O] of KBs)

86
Q

LIPOGENESIS

A

Many tissues are capable of FA (TG) synthesis:

e.g., liver, adipose, lactating mammary gland, kidney, brain, lung

87
Q

LIPID METABOLISM: PROLONGED FASTING

i.e.,3 days and onward

A
  1. liver glycogen stores depleted
  2. gluconeogenesis in liver (kidney?) sustains bld glu
  3. mobilization of adipose TG continues same as in
    postabsorptive state (short fast)
  4. liver begins to produce ketone bodies (KBs) as an
    alternate fuel for brain, kidneys, heart / skeletal muscle
    (replaces some glu used by brain / nerves)
88
Q

KETOGENESIS (KB production):

A

production of β-OH-butyrate, acetoacetate, acetone
(true K) by liver from acetyl-CoA from FA [O]
1. depletion of malate (TCA) to support gluconeogenesis
→ ↓ oxaloacetate to support TCA [O]
2. rate of “delivery” of FFAs to liver remains high
- excess liver nrg (ATP) if FAs completely [O] (β and
TCA [O])
3. FAs → acetyl CoA → KB (liver) → blood → body
tissue
- production of an alternate nrg source
- brain + nervous tissue → spares glu
- muscle ptn → spares AAs (↓ proteolysis)
4. utilization of KBs by extrahepatic tissues
e.g., brain, nervous tis, kidneys, skeletal/heart muscle
- acetone expired in lungs (“acid” breath)
- all mitochondrial
β-OH butyrate → acetoacetate → 2 acetyl-CoA (thru TCAcycle)
→ CO2 + H2O + ATP + etc

89
Q

malate maintains

A

blood glucose levels

90
Q

LIPID METABOLISM: PROLONGED FASTING

KETOSIS:

A
  • KB in blood (ketonemia) and urine (ketonuria) > normal
  • β-OH-butyrate and acetoacetate are acids → ↓ bld pH
  • normally not a problem
    e. g., mild starvation, low CHO diets
  • can be problem in uncontrolled diabetes
  • excess KB excretion in urine depletes alkali reserve
    e. g., bicarbonate, potassium, ammonium ions
91
Q

BLOOD LIPIDS

LP classes and composition (1-5 are globulins)

A
  1. chylomicra - ↑↑ fat ↓ increasing densities
  2. VLDL - ↑ fat (TG)
  3. IDL – short lived
  4. LDL - ↑ chol
  5. HDL - ↑ PLs
  6. VHDL - albumin, ↓ fat, some FAs
92
Q

BLOOD LIPIDS

Transport Mechanisms:

A
  1. Chylomicra : carry diet fats (TG) absorbed from gut → adipose
    (+ tissues with lipoptn lipase)
  2. VLDL: carry endogenous TGs (ie, liver) → adipose (+ other tissues)
  3. LDL: cholesterol → peripheral tissue
  4. HDL: - aids (as UFA donor) in conversion of
    chol → chol ester
    - tissue chol → liver → bile excretion
  5. VHDL: - LPs after lipids removed → liver (reutilized)
    - FAs from adipose → albumin bound, FAs → tissue
93
Q

CONCERNS ABOUT LIPIDS

A
  1. Lipid deposition in atherosclerosis (CHD)
    - multi-factor disease
    - risks: genetic
    environmental – smoking
    - diabetes
    - hypertension
    - lack of exercise
    - gross obesity
    - ↑ blood cholesterol
94
Q
  1. The hyperlipidemias (hyperlipoproteinemia)
A

Inherited (inborn errors of metabolism)
a. Type I: absence of lipoptn lipase (breaks tg bonds so that they can be delivered to various tissues- without enzyme would perscribe diet iwht medium and short chain fatty acids so that they dont have to go in a chylomicron)
b. Type II: ↑↑↑ LDL (cholesterol)
c. Type III: ↑ cholesterol & ↑ TG
d. Type IV: ↑ VLDL (TG)
Secondary hyperlipidemias
Environmental Factors: e.g., ↑ calories, ↑ EOH

know 1 and 2

95
Q

Dietary Fats: Total Fat and Fatty Acids

 Total Fat

A

 AI and RDA not set because insufficient data to
determine a defined level of fat intake at which risk
of inadequacy or prevention of chronic disease
occurs
 UL not set because no defined intake level at which
an adverse event occurs
 AMDR =
 30 - 40% of nrg for children (1-3 y)
 25 - 35% of nrg for children (4-18 y)
 20 - 35% of nrg for adults (old RNIs 30%)

96
Q

Saturated Fat (SFA) & Trans Fat

A

AI and RDA not set because insufficient data to
determine a defined level of SFA or TFA intake at which
prevention of chronic disease occurs
 UL not set, however, positive linear between SFA and
LDL-C and increase risk of CHD could be basis of UL of
zero
 Not possible because all fats contain some SFA
 Recommendation that SFA and TFA be as low as
possible

transfat has to be removed from all products - except for the trans in dairy, meat

97
Q

 Monounsaturated Fat (oleic acid 18:1n9)

A

 AI not set because MUFA synthesized in the body

 UL not set due to insufficient evidence

98
Q

 n-6 PUFA (linoleic acid 18:2n6)

A

AI set for all age/sex groups (range 11 - 17 g/d in
adult)
 UL not set due to insufficient evidence
 AMDR = 5 – 10% of nrg

99
Q

 n-3 PUFA (ALA 18:3n3, EPA 20:5n3, DHA 22;6n3)

A

 AI set for all age/sex groups (range 1.1 - 1.6 g/d in adult)
 Mostly ALA, EPA & DHA can contribute up to 10% of n-3 intake
 UL not set due to insufficient evidence
 AMDR = 0.6 – 1.2% of nrg

100
Q

LIPID METABOLISM

OXIDATION

A

Many tissues (except obligate glucose users) can use
FFAs as a source of energy (through β-[O])
e.g., liver, heart (also [O] of KBs), skeletal muscle (also [O] of KBs)

101
Q

LIPOGENESIS

A

Many tissues are capable of FA (TG) synthesis:

e.g., liver, adipose, lactating mammary gland, kidney, brain, lung

102
Q

LIPID METABOLISM: PROLONGED FASTING

i.e.,3 days and onward

A
  1. liver glycogen stores depleted
  2. gluconeogenesis in liver (kidney?) sustains bld glu
  3. mobilization of adipose TG continues same as in
    postabsorptive state (short fast)
  4. liver begins to produce ketone bodies (KBs) as an
    alternate fuel for brain, kidneys, heart / skeletal muscle
    (replaces some glu used by brain / nerves)
103
Q

KETOGENESIS (KB production):

A

production of β-OH-butyrate, acetoacetate, acetone
(true K) by liver from acetyl-CoA from FA [O]
1. depletion of malate (TCA) to support gluconeogenesis
→ ↓ oxaloacetate to support TCA [O]
2. rate of “delivery” of FFAs to liver remains high
- excess liver nrg (ATP) if FAs completely [O] (β and
TCA [O])
3. FAs → acetyl CoA → KB (liver) → blood → body
tissue
- production of an alternate nrg source
- brain + nervous tissue → spares glu
- muscle ptn → spares AAs (↓ proteolysis)
4. utilization of KBs by extrahepatic tissues
e.g., brain, nervous tis, kidneys, skeletal/heart muscle
- acetone expired in lungs (“acid” breath)
- all mitochondrial
β-OH butyrate → acetoacetate → 2 acetyl-CoA (thru TCAcycle)
→ CO2 + H2O + ATP + etc

104
Q

malate maintains

A

blood glucose levels

105
Q

LIPID METABOLISM: PROLONGED FASTING

KETOSIS:

A
  • KB in blood (ketonemia) and urine (ketonuria) > normal
  • β-OH-butyrate and acetoacetate are acids → ↓ bld pH
  • normally not a problem
    e. g., mild starvation, low CHO diets
  • can be problem in uncontrolled diabetes
  • excess KB excretion in urine depletes alkali reserve
    e. g., bicarbonate, potassium, ammonium ions
106
Q

BLOOD LIPIDS

LP classes and composition (1-5 are globulins)

A
  1. chylomicra - ↑↑ fat ↓ increasing densities
  2. VLDL - ↑ fat (TG)
  3. IDL – short lived
  4. LDL - ↑ chol
  5. HDL - ↑ PLs
  6. VHDL - albumin, ↓ fat, some FAs
107
Q

BLOOD LIPIDS

Transport Mechanisms:

A
  1. Chylomicra : carry diet fats (TG) absorbed from gut → adipose
    (+ tissues with lipoptn lipase)
  2. VLDL: carry endogenous TGs (ie, liver) → adipose (+ other tissues)
  3. LDL: cholesterol → peripheral tissue
  4. HDL: - aids (as UFA donor) in conversion of
    chol → chol ester
    - tissue chol → liver → bile excretion
  5. VHDL: - LPs after lipids removed → liver (reutilized)
    - FAs from adipose → albumin bound, FAs → tissue
108
Q

CONCERNS ABOUT LIPIDS

A
  1. Lipid deposition in atherosclerosis (CHD)
    - multi-factor disease
    - risks: genetic
    environmental – smoking
    - diabetes
    - hypertension
    - lack of exercise
    - gross obesity
    - ↑ blood cholesterol
109
Q
  1. The hyperlipidemias (hyperlipoproteinemia)
A

Inherited (inborn errors of metabolism)
a. Type I: absence of lipoptn lipase (breaks tg bonds so that they can be delivered to various tissues- without enzyme would perscribe diet iwht medium and short chain fatty acids so that they dont have to go in a chylomicron)
b. Type II: ↑↑↑ LDL (cholesterol)
c. Type III: ↑ cholesterol & ↑ TG
d. Type IV: ↑ VLDL (TG)
Secondary hyperlipidemias
Environmental Factors: e.g., ↑ calories, ↑ EOH

know 1 and 2

110
Q

Dietary Fats: Total Fat and Fatty Acids

 Total Fat

A

 AI and RDA not set because insufficient data to
determine a defined level of fat intake at which risk
of inadequacy or prevention of chronic disease
occurs
 UL not set because no defined intake level at which
an adverse event occurs
 AMDR =
 30 - 40% of nrg for children (1-3 y)
 25 - 35% of nrg for children (4-18 y)
 20 - 35% of nrg for adults (old RNIs 30%)

111
Q

Saturated Fat (SFA) & Trans Fat

A

AI and RDA not set because insufficient data to
determine a defined level of SFA or TFA intake at which
prevention of chronic disease occurs
 UL not set, however, positive linear between SFA and
LDL-C and increase risk of CHD could be basis of UL of
zero
 Not possible because all fats contain some SFA
 Recommendation that SFA and TFA be as low as
possible

transfat has to be removed from all products - except for the trans in dairy, meat

112
Q

 Monounsaturated Fat (oleic acid 18:1n9)

A

 AI not set because MUFA synthesized in the body

 UL not set due to insufficient evidence

113
Q

 n-6 PUFA (linoleic acid 18:2n6)

A

AI set for all age/sex groups (range 11 - 17 g/d in
adult)
 UL not set due to insufficient evidence
 AMDR = 5 – 10% of nrg

114
Q

 n-3 PUFA (ALA 18:3n3, EPA 20:5n3, DHA 22;6n3)

A

 AI set for all age/sex groups (range 1.1 - 1.6 g/d in adult)
 Mostly ALA, EPA & DHA can contribute up to 10% of n-3 intake
 UL not set due to insufficient evidence
 AMDR = 0.6 – 1.2% of nrg

115
Q

 Dietary Cholesterol

A

 AI and RDA not set since all tissues synthesize sufficient
amounts of cholesterol
 UL not set, however, recommended that cholesterol consumption
be as low as possible while consuming a nutritionally adequate
diet

116
Q

Nutritional Value of Eggs

A
High Quality Protein
Vitamins
Minerals &amp;
Trace Elements
Essential
Fatty Acids
Low in
Saturated
Fats
Other Bioactive
Compounds

harvard said that fat is bad

117
Q

Current State of Knowledge

A

 Saturated fats and trans-fatty acids increase LDL cholesterol
 Dietary cholesterol has much lower impact on total and LDL
serum cholesterol levels than earlier predictions
 Need to consider LDL:HDL ratio
 Prospective study by Hu et al. (1999) reported no association
with egg consumption and cardiovascular disease in healthy
adults
 Exception: Diabetic subjects
 Do we need to limit egg intake in general population?

118
Q

LIPID METABOLISM

OXIDATION

A

Many tissues (except obligate glucose users) can use
FFAs as a source of energy (through β-[O])
e.g., liver, heart (also [O] of KBs), skeletal muscle (also [O] of KBs)

119
Q

LIPOGENESIS

A

Many tissues are capable of FA (TG) synthesis:

e.g., liver, adipose, lactating mammary gland, kidney, brain, lung

120
Q

LIPID METABOLISM: PROLONGED FASTING

i.e.,3 days and onward

A
  1. liver glycogen stores depleted
  2. gluconeogenesis in liver (kidney?) sustains bld glu
  3. mobilization of adipose TG continues same as in
    postabsorptive state (short fast)
  4. liver begins to produce ketone bodies (KBs) as an
    alternate fuel for brain, kidneys, heart / skeletal muscle
    (replaces some glu used by brain / nerves)
121
Q

KETOGENESIS (KB production):

A

production of β-OH-butyrate, acetoacetate, acetone
(true K) by liver from acetyl-CoA from FA [O]
1. depletion of malate (TCA) to support gluconeogenesis
→ ↓ oxaloacetate to support TCA [O]
2. rate of “delivery” of FFAs to liver remains high
- excess liver nrg (ATP) if FAs completely [O] (β and
TCA [O])
3. FAs → acetyl CoA → KB (liver) → blood → body
tissue
- production of an alternate nrg source
- brain + nervous tissue → spares glu
- muscle ptn → spares AAs (↓ proteolysis)
4. utilization of KBs by extrahepatic tissues
e.g., brain, nervous tis, kidneys, skeletal/heart muscle
- acetone expired in lungs (“acid” breath)
- all mitochondrial
β-OH butyrate → acetoacetate → 2 acetyl-CoA (thru TCAcycle)
→ CO2 + H2O + ATP + etc

122
Q

malate maintains

A

blood glucose levels

123
Q

LIPID METABOLISM: PROLONGED FASTING

KETOSIS:

A
  • KB in blood (ketonemia) and urine (ketonuria) > normal
  • β-OH-butyrate and acetoacetate are acids → ↓ bld pH
  • normally not a problem
    e. g., mild starvation, low CHO diets
  • can be problem in uncontrolled diabetes
  • excess KB excretion in urine depletes alkali reserve
    e. g., bicarbonate, potassium, ammonium ions
124
Q

BLOOD LIPIDS

LP classes and composition (1-5 are globulins)

A
  1. chylomicra - ↑↑ fat ↓ increasing densities
  2. VLDL - ↑ fat (TG)
  3. IDL – short lived
  4. LDL - ↑ chol
  5. HDL - ↑ PLs
  6. VHDL - albumin, ↓ fat, some FAs
125
Q

BLOOD LIPIDS

Transport Mechanisms:

A
  1. Chylomicra : carry diet fats (TG) absorbed from gut → adipose
    (+ tissues with lipoptn lipase)
  2. VLDL: carry endogenous TGs (ie, liver) → adipose (+ other tissues)
  3. LDL: cholesterol → peripheral tissue
  4. HDL: - aids (as UFA donor) in conversion of
    chol → chol ester
    - tissue chol → liver → bile excretion
  5. VHDL: - LPs after lipids removed → liver (reutilized)
    - FAs from adipose → albumin bound, FAs → tissue
126
Q

CONCERNS ABOUT LIPIDS

A
  1. Lipid deposition in atherosclerosis (CHD)
    - multi-factor disease
    - risks: genetic
    environmental – smoking
    - diabetes
    - hypertension
    - lack of exercise
    - gross obesity
    - ↑ blood cholesterol
127
Q
  1. The hyperlipidemias (hyperlipoproteinemia)
A

Inherited (inborn errors of metabolism)
a. Type I: absence of lipoptn lipase (breaks tg bonds so that they can be delivered to various tissues- without enzyme would perscribe diet iwht medium and short chain fatty acids so that they dont have to go in a chylomicron)
b. Type II: ↑↑↑ LDL (cholesterol)
c. Type III: ↑ cholesterol & ↑ TG
d. Type IV: ↑ VLDL (TG)
Secondary hyperlipidemias
Environmental Factors: e.g., ↑ calories, ↑ EOH

know 1 and 2

128
Q

Dietary Fats: Total Fat and Fatty Acids

 Total Fat

A

 AI and RDA not set because insufficient data to
determine a defined level of fat intake at which risk
of inadequacy or prevention of chronic disease
occurs
 UL not set because no defined intake level at which
an adverse event occurs
 AMDR =
 30 - 40% of nrg for children (1-3 y)
 25 - 35% of nrg for children (4-18 y)
 20 - 35% of nrg for adults (old RNIs 30%)

129
Q

Saturated Fat (SFA) & Trans Fat

A

AI and RDA not set because insufficient data to
determine a defined level of SFA or TFA intake at which
prevention of chronic disease occurs
 UL not set, however, positive linear between SFA and
LDL-C and increase risk of CHD could be basis of UL of
zero
 Not possible because all fats contain some SFA
 Recommendation that SFA and TFA be as low as
possible

transfat has to be removed from all products - except for the trans in dairy, meat

130
Q

 Monounsaturated Fat (oleic acid 18:1n9)

A

 AI not set because MUFA synthesized in the body

 UL not set due to insufficient evidence

131
Q

 n-6 PUFA (linoleic acid 18:2n6)

A

AI set for all age/sex groups (range 11 - 17 g/d in
adult)
 UL not set due to insufficient evidence
 AMDR = 5 – 10% of nrg

132
Q

 n-3 PUFA (ALA 18:3n3, EPA 20:5n3, DHA 22;6n3)

A

 AI set for all age/sex groups (range 1.1 - 1.6 g/d in adult)
 Mostly ALA, EPA & DHA can contribute up to 10% of n-3 intake
 UL not set due to insufficient evidence
 AMDR = 0.6 – 1.2% of nrg

133
Q

 Dietary Cholesterol

A

 AI and RDA not set since all tissues synthesize sufficient
amounts of cholesterol
 UL not set, however, recommended that cholesterol consumption
be as low as possible while consuming a nutritionally adequate
diet

134
Q

Nutritional Value of Eggs

A
High Quality Protein
Vitamins
Minerals &amp;
Trace Elements
Essential
Fatty Acids
Low in
Saturated
Fats
Other Bioactive
Compounds

harvard said that fat is bad

135
Q

Current State of Knowledge

A

 Saturated fats and trans-fatty acids increase LDL cholesterol
 Dietary cholesterol has much lower impact on total and LDL
serum cholesterol levels than earlier predictions
 Need to consider LDL:HDL ratio
 Prospective study by Hu et al. (1999) reported no association
with egg consumption and cardiovascular disease in healthy
adults
 Exception: Diabetic subjects
 Do we need to limit egg intake in general population?

never tested to see if eggs increase serum cholesterol

136
Q

chapter 8 integration of metabolism-

A

some might have good review slides

137
Q

t and f with justification, 10 multiple choice, describe question in nutrition context
short answer, more specific in fat
will be some choice

A

j